QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序作者升序作者降序提交时间升序提交时间降序题名升序题名降序 Arnicolide D exerts anti-melanoma effects and inhibits the NF-κB pathway 期刊论文 2019, 卷号: 64, 页码: 153065 作者:  Zhu Peili;  Zheng Zhongyu;  Fu Xiuqiong;  Li Junkui;  Yin Chengle 收藏  |  浏览/下载：25/0  |  提交时间：2020/01/03 Apoptosis  Arnicolide D  Cell cycle arrest  Melanoma  NF-κB   Genome re-sequencing reveals the history of apple and supports a two-stage model for fruit enlargement 期刊论文 2017, 卷号: 8, 期号: 1 作者:  Duan, Naibin[1,2];  Bai, Yang[3];  Sun, Honghe[3];  Wang, Nan[1];  Ma, Yumin[2] 收藏  |  浏览/下载：36/0  |  提交时间：2019/12/28 Self-assembled dual-modality contrast agents for non-invasive stem cell tracking via near-infrared fluorescence and magnetic resonance imaging 期刊论文 Journal of colloid and interface science, 2016 作者:  Liu, Hong;  Tan, Yan;  Xie, Lisi;  Yang, Lei;  Zhao, Jing 收藏  |  浏览/下载：45/0  |  提交时间：2017/01/15 Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2013, 卷号: 56, 期号: 3 作者:  Wang, Deping;  Feng, Yubing;  Zhuang, Xiaoxi;  Zhang, Fengxiang;  Liu, Jianqi 收藏  |  浏览/下载：26/0  |  提交时间：2018/12/13 Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2013, 卷号: 56, 期号: 3 Ren, Xiaomei; Pan, Xiaofen; Zhang, Zhang; Wang, Deping; Lu, Xiaoyun; Li, Yupeng; Wen, Donghai; Long, Huoyou; Luo, Jinfeng; Feng, Yubing; Zhuang, Xiaoxi; Zhang, Fengxiang; Liu, Jianqi; Leng, Fang; Lang, Xingfen; Bai, Yang; She, Miaoqin; Tu, Zhengchao; Pan, Jingxuan; Ding, Ke 收藏  |  浏览/下载：27/0  |  提交时间：2016/12/16 Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: A multicentre, randomised, double-blind study 期刊论文 International Journal of Clinical Practice, Supplement, 2004, 期号: 145 作者:  Zhu, Junren/7405693800[0];  Bai, Jin/36853803900[1];  Cai, Naisheng/7007040687[2];  Tang, B./56238843900[3];  Fan, Weihu/7401635331[4] 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/27 Angiotensin II receptor blocker  Antihypertensives  Hypertension  Losartan  Telmisartan